The marijuana market outlook for 2026 has shifted significantly following the to immediately reclassify FDA-approved and state-licensed medical marijuana products as Schedule III substances . This landmark move is expected to drastically improve cash flows for U.S. operators by removing the IRS 280E tax burden , which previously prevented these businesses from deducting ordinary expenses.

Analysts project the global cannabis market to reach between . Growth is being driven by the expansion of U.S. adult-use markets and a "full market reset" as companies shift toward financial discipline and operational profitability. Top Marijuana Stocks to Watch for 2026 Trulieve Cannabis Corp